
Please try another search
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China. The company offers APIs, including peptides, small molecules, and oligonucleotides; and intermediate products, such as fulvestrant, oseltamivir, and other intermediates. It also provides CRDMO/CMO services. The company was founded in 2009 and is headquartered in Hangzhou City, China.
Name | Age | Since | Title |
---|---|---|---|
Wenyan Hu | 55 | 2019 | Independent Director |
Yan Jiang | 50 | 2022 | Director |
Feng Qu | 50 | 2019 | Independent Director |
Fuqiang Jin | 62 | 2017 | Vice Chairman |
Deyi Zhao | 62 | 2009 | Director |
Dezhong Zhao | 57 | 2009 | Director |
Yuming Pan | 63 | 2017 | Director |
Qiangguo Xu | 61 | 2019 | Independent Director |
Meilu Sun | 53 | 2015 | Chairman of the Supervisory Board |
Guoqiang Shi | 64 | 2017 | Senior VP & Director |
Xiping Qin | 50 | 2022 | Supervisor |
Ziquan Tong | 55 | 2018 | GM & Chairman |
Jifu Gao | 73 | 2019 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review